Takeyama M

No ORCID on file · 2 papers in corpus · active 2014-2022

Study types

  • other 1

Condition tags

  • endometriosis 1
2022
BioMed research international ·doi:10.1155/2022/2209609

The rapid detection of etiological agents is important for the successful treatment of iliopsoas abscess (IPA). The purpose of this study was to investigate the clinical utility of a real-time polymerase chain reaction (PCR) that targets th…

other 2014
European journal of pharmacology ·doi:10.1016/j.ejphar.2013.12.001

TAK-385 (relugolix) is a novel, non-peptide, orally active gonadotropin-releasing hormone (GnRH) antagonist, which builds on previous work with non-peptide GnRH antagonist TAK-013. TAK-385 possesses higher affinity and more potent antagonis…